IMP-A-SDB.ST Stock - Implantica AG
Unlock GoAI Insights for IMP-A-SDB.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.94M | $1.41M | $842,000 | $387,000 | $152,000 |
| Gross Profit | $-1,116,000 | $91,000 | $-421,000 | $-867,000 | $-1,080,000 |
| Gross Margin | -57.6% | 6.5% | -50.0% | -224.0% | -710.5% |
| Operating Income | $-25,466,000 | $-21,840,000 | $-18,447,000 | $-13,141,000 | $-10,641,000 |
| Net Income | $-23,333,000 | $-23,744,000 | $-20,824,000 | $-15,361,000 | $-10,277,000 |
| Net Margin | -1205.2% | -1686.4% | -2473.2% | -3969.3% | -6761.2% |
| EPS | $-0.08 | $-0.08 | $-0.07 | $-0.05 | $-0.04 |
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, it develops UriControl, a remote controlled implant to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and MS patients to urinate on demand using the wireless platform. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica AG is a subsidiary of Implantica MediSwiss.
Visit WebsiteEarnings History & Surprises
IMP-A-SDB.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 19, 2026 | — | — | — | — |
Q4 2025 | Oct 31, 2025 | $-0.08 | $-7.65 | -9858.3% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | $-0.12 | $-0.22 | -87.1% | ✗ MISS |
Q2 2025 | May 9, 2025 | $-0.12 | $-0.04 | +66.7% | ✓ BEAT |
Q1 2025 | Feb 14, 2025 | $-0.09 | $-0.10 | -11.1% | ✗ MISS |
Q4 2024 | Nov 15, 2024 | $-0.11 | $-0.09 | +18.2% | ✓ BEAT |
Q3 2024 | Aug 21, 2024 | $-0.16 | $-0.09 | +43.8% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $-0.16 | $-0.05 | +68.8% | ✓ BEAT |
Q1 2024 | Feb 16, 2024 | $-0.10 | $-0.12 | -20.0% | ✗ MISS |
Q4 2023 | Nov 22, 2023 | $-0.08 | $-0.22 | -178.1% | ✗ MISS |
Q3 2023 | Aug 24, 2023 | $-0.09 | $-0.07 | +22.2% | ✓ BEAT |
Q2 2023 | May 12, 2023 | $-0.10 | $-0.07 | +30.0% | ✓ BEAT |
Q1 2023 | Feb 17, 2023 | $-0.08 | $-0.07 | +12.5% | ✓ BEAT |
Q4 2022 | Nov 15, 2022 | $-0.11 | $-0.08 | +27.3% | ✓ BEAT |
Q3 2022 | Aug 23, 2022 | $-0.09 | $-0.08 | +11.1% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $-0.08 | $-0.07 | +12.5% | ✓ BEAT |
Q1 2022 | Feb 18, 2022 | $-0.07 | $-0.09 | -28.6% | ✗ MISS |
Q4 2021 | Nov 24, 2021 | $-0.14 | $-0.06 | +57.1% | ✓ BEAT |
Q3 2021 | Aug 24, 2021 | $-0.04 | $-0.04 | 0.0% | = MET |
Q2 2021 | May 12, 2021 | $-0.07 | $-0.04 | +42.9% | ✓ BEAT |
Latest News
Frequently Asked Questions about IMP-A-SDB.ST
What is IMP-A-SDB.ST's current stock price?
What is the analyst price target for IMP-A-SDB.ST?
What sector is Implantica AG in?
What is IMP-A-SDB.ST's market cap?
Does IMP-A-SDB.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IMP-A-SDB.ST for comparison